Robert Cho

Person

Sunnyvale, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Bromodomain and extra-terminal protein inhibitor combination therapy
- Patent number 11,464,771
- Issue date Oct 11, 2022
- Celgene Quanticel Research, Inc.
- Robert Cho
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of relapsed and/or refractory solid tumors and non-hodgki...
- Patent number 10,960,005
- Issue date Mar 30, 2021
- Celgene Quanticel Research, Inc.
- Jiangchun Xu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bromodomain and extra-terminal protein inhibitor combination therapy
- Patent number 10,881,655
- Issue date Jan 5, 2021
- Celgene Quanticel Research, Inc.
- Robert Cho
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of relapsed and/or refractory solid tumors and non-Hodgki...
- Patent number 10,849,898
- Issue date Dec 1, 2020
- Celgene Quanticel Research, Inc.
- Jiangchun Xu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bromodomain and extra-terminal protein inhibitor combination therapy
- Patent number 10,576,075
- Issue date Mar 3, 2020
- Celgene Quanticel Research, Inc.
- Robert Cho
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of relapsed and/or refractory solid tumors and non-Hodgki...
- Patent number 10,548,896
- Issue date Feb 4, 2020
- Celgene Quanticel Research, Inc.
- Jiangchun Xu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of relapsed and/or refractory solid tumors and non-hodgki...
- Patent number 10,543,213
- Issue date Jan 28, 2020
- Celgene Quanticel Research, Inc.
- Jiangchun Xu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of relapsed and/or refractory solid tumors and non-hodgki...
- Patent number 10,328,077
- Issue date Jun 25, 2019
- Celgene Corporation
- Jiangchun Xu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bromodomain and extra-terminal protein inhibitor combination therapy
- Patent number 10,166,227
- Issue date Jan 1, 2019
- Celgene Quanticel Research, Inc.
- Robert Cho
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
BROMODOMAIN AND EXTRA-TERMINAL PROTEIN INHIBITOR COMBINATION THERAPY
- Publication number 20210008056
- Publication date Jan 14, 2021
- Celgene Quanticel Research, Inc.
- Robert Cho
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF RELAPSED AND/OR REFRACTORY SOLID TUMORS AND NON-HODGKI...
- Publication number 20200297727
- Publication date Sep 24, 2020
- Celgene Quanticel Research, Inc.
- Jiangchun XU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BROMODOMAIN AND EXTRA-TERMINAL PROTEIN INHIBITOR COMBINATION THERAPY
- Publication number 20200155539
- Publication date May 21, 2020
- Celgene Quanticel Research, Inc.
- Robert Cho
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF RELAPSED AND/OR REFRACTORY SOLID TUMORS AND NON-HODGKI...
- Publication number 20200113905
- Publication date Apr 16, 2020
- Celgene Quanticel Research, Inc.
- Jiangchun XU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF RELAPSED AND/OR REFRACTORY SOLID TUMORS AND NON-HODGKI...
- Publication number 20190240222
- Publication date Aug 8, 2019
- Celgene Corporation
- Jiangchun Xu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF RELAPSED AND/OR REFRACTORY SOLID TUMORS AND NON-HODGKI...
- Publication number 20190240223
- Publication date Aug 8, 2019
- Celgene Corporation
- Jiangchun Xu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BROMODOMAIN AND EXTRA-TERMINAL PROTEIN INHIBITOR COMBINATION THERAPY
- Publication number 20190083483
- Publication date Mar 21, 2019
- Celgene Quanticel Research, Inc.
- Robert Cho
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF RELAPSED AND/OR REFRACTORY SOLID TUMORS AND NON-HODGKI...
- Publication number 20180125844
- Publication date May 10, 2018
- Celgene Corporation
- Jiangchun Xu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BROMODOMAIN AND EXTRA-TERMINAL PROTEIN INHIBITOR COMBINATION THERAPY
- Publication number 20180117030
- Publication date May 3, 2018
- Celgene Quanticel Research, Inc.
- Robert Cho
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BROMODOMAIN AND EXTRA-TERMINAL PROTEIN INHIBITOR COMBINATION THERAPY
- Publication number 20170182025
- Publication date Jun 29, 2017
- Celgene Quanticel Research, Inc.
- Zariana Nikolova
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Person

Patents Grantslast 30 patents

Bromodomain and extra-terminal protein inhibitor combination therapy

Treatment of relapsed and/or refractory solid tumors and non-hodgki...

Bromodomain and extra-terminal protein inhibitor combination therapy

Treatment of relapsed and/or refractory solid tumors and non-Hodgki...

Bromodomain and extra-terminal protein inhibitor combination therapy

Treatment of relapsed and/or refractory solid tumors and non-Hodgki...

Treatment of relapsed and/or refractory solid tumors and non-hodgki...

Treatment of relapsed and/or refractory solid tumors and non-hodgki...

Bromodomain and extra-terminal protein inhibitor combination therapy

Patents Applicationslast 30 patents

BROMODOMAIN AND EXTRA-TERMINAL PROTEIN INHIBITOR COMBINATION THERAPY

TREATMENT OF RELAPSED AND/OR REFRACTORY SOLID TUMORS AND NON-HODGKI...

BROMODOMAIN AND EXTRA-TERMINAL PROTEIN INHIBITOR COMBINATION THERAPY

TREATMENT OF RELAPSED AND/OR REFRACTORY SOLID TUMORS AND NON-HODGKI...

TREATMENT OF RELAPSED AND/OR REFRACTORY SOLID TUMORS AND NON-HODGKI...

TREATMENT OF RELAPSED AND/OR REFRACTORY SOLID TUMORS AND NON-HODGKI...

BROMODOMAIN AND EXTRA-TERMINAL PROTEIN INHIBITOR COMBINATION THERAPY

TREATMENT OF RELAPSED AND/OR REFRACTORY SOLID TUMORS AND NON-HODGKI...

BROMODOMAIN AND EXTRA-TERMINAL PROTEIN INHIBITOR COMBINATION THERAPY

BROMODOMAIN AND EXTRA-TERMINAL PROTEIN INHIBITOR COMBINATION THERAPY